← The Wire
AURANasdaq
Aura Biosciences, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1501796
Develops precision immunotherapies for solid tumors, aiming to preserve organ function
red 8-K · 90d
$663M
Market cap
$6.88
Last close
-1.7%
1D
-1.0%
5D
383K
Volume
Price · last 39 sessions-17.6%
May 4L $6.12 · H $8.90Jun 29
104
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AJun 29, 20268-KShareholder VoteJun 11, 202610-Q10-QMay 11, 20268-KResults of Operations · Company UpdateMay 11, 2026SC 13D/ASC 13D/AMay 11, 20268-KMaterial AgreementMay 5, 2026424B5424B5May 5, 20268-KMaterial Agreement · Results of OperationsMay 4, 2026DEFA14ADEFA14AMay 4, 2026424B5424B5May 4, 20268-KExecutive Change · Reg FD DisclosureMay 4, 2026DEFA14ADEFA14AApr 20, 2026DEF 14ADEF 14AApr 20, 202610-K10-KMar 30, 20268-KResults of Operations · Company UpdateMar 30, 202610-Q10-QNov 13, 20258-KResults of Operations · Company UpdateNov 13, 202510-Q10-QAug 13, 20258-KResults of Operations · Company UpdateAug 13, 20258-KShareholder VoteJun 18, 20258-KMaterial Agreement · Company UpdateMay 16, 2025424B5424B5May 16, 2025424B5424B5May 15, 202510-Q10-QMay 15, 20258-KExecutive Change · Results of OperationsMay 15, 2025DEFA14ADEFA14AApr 24, 2025DEF 14ADEF 14AApr 24, 20258-KExecutive ChangeApr 2, 202510-K10-KMar 24, 20258-KResults of Operations · Company UpdateMar 24, 202510-Q10-QNov 12, 20248-KResults of Operations · Company UpdateNov 12, 2024SC 13GSC 13GNov 8, 2024SC 13GSC 13GOct 22, 20248-KReg FD Disclosure · Company UpdateOct 17, 20248-KExecutive ChangeSep 27, 20248-KReg FD Disclosure · Company UpdateSep 12, 202410-Q10-QAug 8, 20248-KResults of Operations · Company UpdateAug 8, 20248-KBylaw Amendment · Shareholder VoteJun 21, 2024DEFA14ADEFA14AJun 14, 202410-K/A10-K/AJun 14, 20248-KCompany UpdateJun 4, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 20248-KExecutive ChangeApr 15, 202410-K10-KMar 27, 20248-KResults of OperationsMar 27, 20248-KCompany UpdateJan 8, 202410-Q10-QNov 9, 20238-KMaterial Agreement · Results of OperationsNov 9, 2023424B5424B5Nov 7, 2023424B5424B5Nov 6, 20238-KReg FD Disclosure · Company UpdateNov 6, 20238-KExecutive ChangeOct 2, 202310-Q10-QAug 9, 20238-KResults of Operations · Company UpdateAug 9, 20238-KShareholder VoteJun 7, 202310-Q10-QMay 11, 20238-KResults of Operations · Company UpdateMay 11, 2023DEFA14ADEFA14AApr 25, 2023DEF 14ADEF 14AApr 25, 20238-KExecutive ChangeApr 4, 202310-K10-KMar 15, 20238-KResults of OperationsMar 15, 20238-KReg FD Disclosure · Company UpdateFeb 16, 2023SC 13GSC 13GFeb 14, 20238-KCompany UpdateJan 6, 2023SC 13GAURA BIOSCIENCES, INC.Dec 15, 20228-KMaterial AgreementDec 5, 2022424B5424B5Dec 1, 2022424B5424B5Nov 30, 20228-KCompany UpdateNov 30, 202210-Q10-QNov 10, 20228-KResults of Operations · Company UpdateNov 10, 20228-KReg FD Disclosure · Company UpdateOct 3, 20228-KReg FD DisclosureSep 28, 202210-Q10-QAug 11, 2022
Insider Activity
In the 90 days to Feb 17, 2026: 5 sold $619K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | De Los Pinos ElisabetSee Remarks | Sell | 47,648 | $5.06 | $241K |
| Feb 17, 2026 | Hopkins Janet JillChief Medical Officer | Sell | 20,401 | $5.06 | $103K |
| Feb 17, 2026 | Plavsic MarkChief Technology Officer | Sell | 15,890 | $5.05 | $80K |
| Feb 17, 2026 | Kilroy ConorSee Remarks | Sell | 12,079 | $5.05 | $61K |
| Feb 17, 2026 | Elazzouzi AmySenior Vice President, Finance | Sell | 8,549 | $5.06 | $43K |
| Jan 20, 2026 | De Los Pinos ElisabetSee Remarks | Sell | 16,928 | $4.86 | $82K |
| Jan 20, 2026 | Elazzouzi AmySenior Vice President, Finance | Sell | 1,581 | $4.86 | $8K |
| Nov 17, 2025 | Hopkins Janet JillChief Medical Officer | Sell | 17,109 | $5.42 | $93K |
| Oct 29, 2025 | De Los Pinos ElisabetSee Remarks | Sell | 9,049 | $6.35 | $57K |
| Oct 29, 2025 | Elazzouzi AmySenior Vice President, Finance | Sell | 896 | $6.35 | $6K |
| Oct 16, 2025 | Plavsic MarkChief Technology Officer | Sell | 12,169 | $6.35 | $77K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance